ARCHIVES

Risk-Benefit Analysis Advised Prior To Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Weekly Paclitaxel Better Than Every Three Weeks

June 25, 2004

Senate Approves 15% Increase For NIH; House Passes 5.6% Raise, But Favors More.

July 7, 2000

Standard Procedures Discarded in Review Of $20 Million in Texas Funds For Project Led by Wife of MD Anderson President

May 25, 2012

HHS Group To Study Policies Affecting Academic Centers

June 20, 1997

NSABP Executive Committee Drops Suit Against Pitt

February 10, 1995

Consensus Conference On Receptors Planned

June 22, 1979